Skip to content

B2-Glycoprotein I (Protein S) Antibody, Serum

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of antibodies against B2-glycoprotein I, a protein involved in blood clotting regulation. It helps assess risks related to blood clots or autoimmune conditions.

Quick summary

["This test may help evaluate clotting disorders or autoimmune conditions by checking for immune system responses to a specific protein."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
40456-6
Short code
B2 Glycoprot1 Ab Ser-aCnc
Synonyms
B2 Glycoprot1 Ab Ser-aCnc
Category
glucose
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your doctor may order this test if you have symptoms like unexplained bruising, blood clots, or signs of autoimmune diseases. It can also be part of a broader evaluation for conditions affecting blood clotting or immune function.

What to Expect Before the Test

No special preparation is needed. You may have a blood sample drawn from a vein in your arm, similar to other blood tests. Wear comfortable clothing if you need an arm sleeve removed.

What the Test Results Mean

Positive results indicate the presence of antibodies against B2-glycoprotein I, which may suggest an autoimmune response. The exact meaning depends on your symptoms and medical history. Your doctor will interpret results in the context of your overall health.

Common Conditions Linked to This Test

This test is often linked to conditions like antiphospholipid syndrome (APS), a disorder causing blood clots or pregnancy complications. It may also be relevant in diagnosing or monitoring autoimmune diseases.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

B2-glycoprotein I is a cofactor in blood clotting pathways. Antibodies against it can interfere with normal clotting processes, increasing the risk of clots or bleeding disorders. This test helps identify patients at risk for autoimmune-related clotting issues or other systemic conditions.

Short name

Protein S Antibody (Serum)

Frequently asked questions

What does a positive test result mean?
A positive result means your immune system has detected antibodies against B2-glycoprotein I. This could be linked to an autoimmune condition like antiphospholipid syndrome or other clotting-related disorders. Your doctor will discuss next steps based on your symptoms and test results.
How often should I get this test?
Your doctor will determine the frequency based on your medical needs. If you have an ongoing condition like APS, follow-up tests may be scheduled periodically to monitor changes in your health.
Can lifestyle changes affect this test result?
While lifestyle factors like diet or stress may influence overall health, they typically do not directly affect antibody levels measured in this test. Focus on managing any underlying conditions your doctor has identified.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy